QIAGEN NV (QGEN)
34.89
-0.20
(-0.57%)
USD |
NYSE |
May 21, 16:00
34.91
+0.02
(+0.06%)
Pre-Market: 19:59
QIAGEN EPS Diluted (Quarterly) : 0.3257 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CDT Equity, Inc. | -231.44 |
| Thermo Fisher Scientific, Inc. | 4.426 |
| ICON plc | 0.0302 |
| InflaRx NV | -0.0905 |
| Adaptive Biotechnologies Corp. | -0.1288 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 68.04M |
| Revenue (Quarterly) | 492.32M |
| Total Expenses (Quarterly) | 424.28M |
| Enterprise Value | 8.188B |
| Gross Profit Margin (Quarterly) | 62.53% |
| Profit Margin (Quarterly) | 13.82% |
| Earnings Yield | 5.55% |
| Operating Earnings Yield | 7.06% |
| Normalized Earnings Yield | 6.315 |